Overblog Alle Blogs
Edit post Folge diesem Blog Administration + Create my blog
MENU

Mein Blog umfasst die aktuellesten News, Forschungsleistung, neuesten Produkte und Service von Sino Biological Inc. und die aktuelle News von Life Sciences. Sie können sich hier wissenschaftlich informieren.Willkommen zu meinem Blog.Viel Spaß!

Werbung

CHK2 / CHEK2 Antikörper (Antigen Affinity Purified)

Sino Biological Inc. liefert CHK2 / CHEK2 Antikörper (Antigen Affinity Purified) mit höherer Qualität und günstiger Kosten im Vergleich mit anderen globalen Lieferanten.

Weitere Informationen über CHK2 / CHEK2 Antikörper (Antigen Affinity Purified) lesen Sie bitte: http://www.sinobiological.com/CHK2-CHEK2-Antibody-g-10086.html

Produkt-Information von CHK2 / CHEK2 Antikörper

Immunogen

Recombinant Mouse CHK2 / CHEK2 protein (Catalog#50432-M20B)

Antibody Type Rabbit Polyclonal Antibody ( Antibody Purification Platform )
Ig Type

Rabbit IgG

Formulation 0.2 μm filtered solution in PBS with 5% trehalose
Preparation

Produced in rabbits immunized with purified, recombinant Mouse CHK2 / CHEK2 (rM CHK2 / CHEK2; Catalog#50432-M20B; Q9Z265; Mey1-Leu 546). CHK2 / CHEK2 specific IgG was purified by Mouse CHK2 / CHEK2 affinity chromatography.

Usage Guide von CHK2 / CHEK2 Antikörper

Specificity

Mouse CHK2 / CHEK2

Immunochemistry

IHC-P: 0.1-2 μg/mL

mCHEK2-mouse-spleen immunohistochemistry    

Immunochemical staining of mouse CHEK2 in mouse spleen with rabbit polyclonal antibody (1 μg/mL, formalin-fixed paraffin embedded sections).  
Storage This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -70℃. Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.

Verwandte Produkte & Themen von CHK2 / CHEK2 Antikörper

Related Areas:

Cancer>>Cell Cycle>>CHK2/CHEK2

Proteins:
Molecule Species Description //For Detailed Info. and Price------CLICK! Cat. No
CHK2/CHEK2 Mouse CHK2/CHEK2 Protein, Recombinant, with GST Tag 50432-M20B
Antibodies:
Molecule Application Description //For Detailed Info. and Price------CLICK! Cat. No
Mouse CHK2/CHEK2 IHC-P CHK2 / CHEK2 Antibody (Antigen Affinity Purified) 50432-RP02

Hintergrund von CHK2 / CHEK2 Antikörper

Serine / threonine-protein kinase Chk2, also known as Cds1 and CHEK2, is a nucleusprotein which belongs to theprotein kinase superfamily, CAMK Ser/Thr protein kinase family and CHK2 subfamily. CHEK2 regulates cell cycle checkpoints and apoptosis in response to DNA damage, particularly to DNA double-strand breaks. CHEK2 inhibits CDC25C phosphatase by phosphorylation on 'Ser-216', preventing the entry into mitosis. CHEK2 may also play a role in meiosis. CHEK2 regulates the TP53 tumor suppressor through phosphorylation at 'Thr-18' and 'Ser-20'. Defects in CHEK2 are associated with Li-Fraumeni syndrome 2 which is a highly penetrant familial cancer phenotype usually associated with inherited mutations in p53 / TP53. Defects in CHEK2 may be a cause of susceptibility to prostate cancer (PC) which is a malignancy originating in tissues of the prostate. Most prostate cancers are adenocarcinomas that develop in the acini of the prostatic ducts. Other rare histopathologic types of prostate cancer that occur in approximately 5% of patients include small cell carcinoma, mucinous carcinoma, prostatic ductal carcinoma, transitional cell carcinoma, squamous cell carcinoma, basal cell carcinoma, adenoid cystic carcinoma (basaloid), signet-ring cell carcinoma and neuroendocrine carcinoma.

References

  1. Matsuoka S. et al., 1998, Science. 282: 1893-1897.
  2. Li J. et al.,2002, Mol Cell. 9: 1045-1054.
  3. Staalesen V. et al., 2004, Oncogene. 23: 8535-44.
  4. Kilpivaara O. et al., 2004, Int J Cancer. 111: 543-7.
  5. Petrinac S. et al., 2009, Cell Cycle. 8: 327-9.

Primary Antibody Products

Werbung
Zurück zu Home
Diesen Post teilen
Repost0
Um über die neuesten Artikel informiert zu werden, abonnieren:
Kommentiere diesen Post